How are Lamivudine And Zidovudine adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lamivudine And Zidovudine is flagged as the suspect drug causing the adverse event.
What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?
Drug Exposure During Pregnancy | 324 (8.54%) |
Premature Baby | 93 (2.45%) |
Stillbirth | 69 (1.82%) |
Abortion Spontaneous | 63 (1.66%) |
Anaemia | 56 (1.48%) |
Congenital Anomaly | 56 (1.48%) |
Abdominal Distension | 41 (1.08%) |
Cardiac Murmur | 41 (1.08%) |
Maternal Drugs Affecting Foetus | 40 (1.05%) |
Ventricular Septal Defect | 40 (1.05%) |
Cryptorchism | 37 (.98%) |
![]() |
Share/Embed Graph
Export Data
This graph shows the top adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?
Chemical Injury And Poisoning | 371 (9.78%) |
Abortions And Stillbirth | 159 (4.19%) |
Neonatal And Perinatal Conditions | 143 (3.77%) |
Musculoskeletal And Connective Tiss... | 126 (3.32%) |
Anemias Nonhemolytic And Marrow Dep... | 113 (2.98%) |
Hepatic And Hepatobiliary | 111 (2.93%) |
Cardiac And Vascular Disorders Cong... | 108 (2.85%) |
Gastrointestinal Signs | 103 (2.72%) |
Infections - Pathogen Unspecified | 89 (2.35%) |
Respiratory | 81 (2.14%) |
Epidermal And Dermal Conditions | 77 (2.03%) |
![]() |
Share/Embed Graph
Export Data
This graph shows the top categories of adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Lamivudine And Zidovudine, according to those reporting adverse events to the FDA?
Hiv Infection | 811 |
Drug Exposure During Pregnancy | 357 |
Drug Use For Unknown Indication | 99 |
Acquired Immunodeficiency Syndrome | 53 |
Prophylaxis Against Hiv Infection | 50 |
Antiretroviral Therapy | 49 |
![]() |
Label | Labeler | Effective |
---|---|---|
Combivir | Stat Rx USA | 27-OCT-09 |
Combivir | Rebel Distributors Corp | 24-SEP-10 |
Combivir | PD-Rx Pharmaceuticals, Inc. | 14-MAR-11 |
Combivir | GlaxoSmithKline LLC | 14-MAR-11 |
Trizivir | GlaxoSmithKline LLC | 13-JUL-11 |
Lamivudine And Zidovudine | PD-Rx Pharmaceuticals, Inc. | 23-DEC-11 |
Combivir | HHS/Program Support Center/Supply Service Center | 03-JAN-12 |
Combivir | H.J. Harkins Company, Inc. | 02-FEB-12 |
Lamivudine And Zidovudine | Rebel Distributors Corp | 04-APR-12 |
Lamivudine And Zidovudine | Lupin Pharmaceuticals, Inc. | 24-APR-12 |
Lamivudine And Zidovudine | Aurobindo Pharma Limited | 15-MAY-12 |
Lamivudine And Zidovudine | Teva Pharmaceuticals USA Inc | 21-MAY-12 |
Trizivir | ViiV Healthcare Company | 22-MAY-12 |
Lamivudine And Zidovudine | H.J. Harkins Company, Inc. | 25-JUN-12 |
Lamivudine And Zidovudine | St Marys Medical Park Pharmacy | 29-AUG-12 |
Combivir | ViiV Healthcare Company | 16-JAN-13 |
Lamivudine And Zidovudine | Bryant Ranch Prepack | 18-JAN-13 |
Combivir | REMEDYREPACK INC. | 11-MAR-13 |
Lamivudine And Zidovudine | REMEDYREPACK INC. | 11-APR-13 |
Lamivudine And Zidovudine | REMEDYREPACK INC. | 11-APR-13 |
Combivir | REMEDYREPACK INC. | 23-APR-13 |
Combivir | REMEDYREPACK INC. | 23-APR-13 |
Combivir | REMEDYREPACK INC. | 23-APR-13 |
What Lamivudine And Zidovudine safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Lamivudine And Zidovudine. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Lamivudine And Zidovudine.